Vaginal Atrophy /Vaginal Dryness Study
Non-hormonal and non-steroidal Women’s Health Study
Quality of life of many women can be significantly impacted by vulvovaginal symptoms such as vaginal dryness, burning sensation, itching and tenderness as well as painful intercourse (dyspareunia), painful urination (dysuria) and bowel movement (defecation). These symptoms can cause significant distress on physical, mental, and sexual health, for women at different stages of their life.
We are enrolling for a non-hormonal and non-steroidal gel for Vaginal atrophy or Lichenoid dermatosis (sclerosus / planus).
To qualify, you must:
- Be 18+
- Be diagnosed atrophic vaginitis, lichen sclerosus, lichen simplex chronicus or lichen planus
- Experience continuous vulvovaginal symptoms
- Have access to smartphone and tablet, laptop or computer
- Have access to a valid email address
Qualified participants may receive a mammogram or ultrasound as part of the study, as well as compensation for time and travel
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.